Ehlerding G - Search Results

1

Antiproteinuric efficacy of fosinopril after renal transplantation is determined by the extent of vascular and tubulointerstitial damage.

Lufft V, Kliem V, Hamkens A, Bleck JS, Eisenberger U, Petersen R, Ehlerding G, Maschek H, Pichlmayr R, Brunkhorst R. Lufft V, et al. Among authors: ehlerding g. Clin Transplant. 1998 Oct;12(5):409-15. Clin Transplant. 1998. PMID: 9787950

2

Risk of renal cell carcinoma after kidney transplantation.

Kliem V, Kolditz M, Behrend M, Ehlerding G, Pichlmayr R, Koch KM, Brunkhorst R. Kliem V, et al. Among authors: ehlerding g. Clin Transplant. 1997 Aug;11(4):255-8. Clin Transplant. 1997. PMID: 9267711

3

Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients.

Kliem V, Schaumann D, Ehlerding G, Eberhard OK, Lufft V, Schlitt HJ, Pichlmayr R, Koch KM, Brunkhorst R. Kliem V, et al. Among authors: ehlerding g. Transplant Proc. 1997 Nov;29(7):2955-7. doi: 10.1016/s0041-1345(97)00743-4. Transplant Proc. 1997. PMID: 9365627 Clinical Trial. No abstract available.

4

Prevention of glomerular hypertrophy and glomerulosclerosis in Milan normotensive rats by low-protein diet, but not by low-dose captopril treatment.

Kliem V, Brunkhorst R, Ehlerding G, Kühn K, Neumann KH, Koch KM. Kliem V, et al. Among authors: ehlerding g. Nephron. 1995;71(2):208-12. doi: 10.1159/000188714. Nephron. 1995. PMID: 8569956

5

Outcome of kidney transplantation in patients with systemic autoimmune diseases.

Kliem V, Haubitz M, Ehlerding G, Nashan B, Schlitt HJ, Oldhafer KJ, Pichlmayr R, Koch KM, Brunkhorst R. Kliem V, et al. Among authors: ehlerding g. Transplant Proc. 1997 Feb-Mar;29(1-2):957-8. doi: 10.1016/s0041-1345(96)00297-7. Transplant Proc. 1997. PMID: 9123606 No abstract available.

6

Successful therapy of chronic renal allograft failure by enhanced immunosuppression.

Kliem V, Tiroke T, Ehlerding G, Eberhard O, Behrend M, Frei U, Koch KM, Pichlmayr R, Brunkhorst R. Kliem V, et al. Among authors: ehlerding g. Transplant Proc. 1998 Jun;30(4):1207-9. doi: 10.1016/s0041-1345(98)00212-7. Transplant Proc. 1998. PMID: 9636490 No abstract available.

7

Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients.

Kliem V, Petersen R, Ehlerding G, Schaumann D, Eisenberger U, Koch KM, Pichlmayr R, Brunkhorst R. Kliem V, et al. Among authors: ehlerding g. Transplant Proc. 1998 Jun;30(4):1251-3. doi: 10.1016/s0041-1345(98)00231-0. Transplant Proc. 1998. PMID: 9636509 No abstract available.

8

Functional significance of portal venous drainage in pancreas transplantation.

Lück R, Klempnauer J, Steiniger B, Ehlerding G, Kühn K, Pichlmayr R. Lück R, et al. Among authors: ehlerding g. Transplant Proc. 1987 Oct;19(5):3915-7. Transplant Proc. 1987. PMID: 3313962 No abstract available.

9

Advanced glycosylated end-products (AGEs) in non-diabetic patients undergoing dialysis.

Brunkhorst R, Kruse M, Ehlerding G, Mahiout A. Brunkhorst R, et al. Among authors: ehlerding g. Clin Nephrol. 1996 Oct;46(4):265-6. Clin Nephrol. 1996. PMID: 8905214 No abstract available.

10

Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients.

Mahiout A, Ehlerding G, Brunkhorst R. Mahiout A, et al. Among authors: ehlerding g. Nephrol Dial Transplant. 1996;11 Suppl 5:2-6. doi: 10.1093/ndt/11.supp5.2. Nephrol Dial Transplant. 1996. PMID: 9044298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page